"We don't feel pressure. We feel pressure to get it right and maintain the standards and to play a big part in helping people get back to normal," Sanofi CEO Paul Hudson told CNBC.
"The strength in the stock of Darden, it should terrify you. Darden's winning because its private competitors can't cope with the Covid-19 economy," CNBC's Jim Cramer said.
Slaoui admitted in a phone interview with CNBC that he still holds shares in GlaxoSmithKline, where he worked for nearly 30 years, and said he plans to use them as part of his retirement.
Trump is expected to discuss the executive orders, which are part of his "America First" health-care plan, during his visit to Charlotte, North Carolina later Thursday.
Dozens of doctors, researchers and other faculty members affiliated with Stanford University wrote an open letter criticizing Trump's coronavirus advisor Dr. Scott Atlas. In return, they say they were threatened with a defamation lawsuit.
There's a lot of confusion because there are mixed messages that are coming," Dr. Anthony Fauci, the director of National Institute of Allergy and Infectious Diseases, said.
Florida prosecutors are dropping prostitution charges against New England Patriots owner Robert Kraft, more than a year after his arrest sparked a scandal for the National Football League.
Nikola shares tumbled Thursday to a record low since the company's public debut in early June after Wedbush downgraded the electric truck maker's stock to underperform from neutral.
John D. Spooner, a financial advisor at Morgan Stanley and author of “No One Ever Told Us That: Money and Life Lessons for Young Adults," shares the top lessons he's learned through decades of experience in the investment business.